Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$64 Mln
P/E Ratio
--
P/B Ratio
-0.69
Industry P/E
30.96
Debt to Equity
0
ROE
-0.06 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-6.74
CFO
CN¥-2,675.34 Mln
EBITDA
CN¥-3,204.53 Mln
Net Profit
CN¥-3,406.95 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
111 - ADR
| 17.82 | -27.61 | 70.70 | -28.04 | -27.92 | -37.24 | -- |
BSE Sensex
| 1.48 | 4.01 | 3.03 | 8.65 | 11.66 | 20.20 | 11.03 |
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
---|---|---|---|---|---|---|
111 - ADR
| -59.51 | -48.68 | -13.71 | -49.64 | 3.27 | 9.61 |
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
12.34 | 6,427.67 | 6.42 | 20.12 |
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products... through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China. Address: No.295 ZuChongZhi Road, Shanghai, China, 201203 Read more
Co-Founder & Executive Chairman
Dr. Gang Yu
Co-Founder & Executive Chairman
Dr. Gang Yu Ph.D.
Headquarters
Shanghai
Website
The total asset value of 111 Inc - ADR stood at $ 5,680 Mln as on 30-Sep-24
The share price of 111 Inc - ADR is $7.34 (NASDAQ) as of 21-Apr-2025 12:21 EDT. 111 Inc - ADR has given a return of -27.92% in the last 3 years.
111 Inc - ADR has a market capitalisation of $ 64 Mln as on 17-Apr-2025. As per Value Research classification, it is a company.
The P/B ratio of 111 Inc - ADR is -0.69 times as on 17-Apr-2025, a 111% discount to its peers’ median range of 6.34 times.
Since, TTM earnings of 111 Inc - ADR is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the 111 Inc - ADR and enter the required number of quantities and click on buy to purchase the shares of 111 Inc - ADR.
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China. Address: No.295 ZuChongZhi Road, Shanghai, China, 201203
The CEO & director of Dr. Gang Yu. is 111 Inc - ADR, and CFO & Sr. VP is Dr. Gang Yu Ph.D..
There is no promoter pledging in 111 Inc - ADR.
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
639
|
111 Inc. - ADR | Ratios |
---|---|
Return on equity(%)
|
--
|
Operating margin(%)
|
0.13
|
Net Margin(%)
|
-0.42
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of 111 Inc - ADR was $0 Mln.